| |
| |
|
| Insider
Information: |
Rodgers Richard J |
| Relationship: |
|
| City: |
Bloomington |
| State: |
MN |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
6 |
|
| Direct
Shares |
760,082 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$1,911,695 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
760,082 |
|
|
| Total
Value |
$1,911,695 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
1
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
1
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
-1.0
|
0.0
|
| Percentage
Gain/Loss : |
 -13.1%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
MGI Pharma Inc |
MOGN |
Sr. VP and Controller |
2008-01-28 |
0 |
2008-01-23 |
0 |
Premium* |
|
|
New Abraxis Inc |
ABII |
Senior Vice President ... |
2009-07-13 |
15,000 |
2009-07-13 |
0 |
Premium* |
|
|
Tesaro, Inc. |
TSRO |
Exec. Vice President &... |
2012-07-03 |
257,141 |
|
0 |
Premium* |
|
|
Ardelyx Inc |
ARDX |
Director |
2023-06-15 |
238,320 |
2015-06-11 |
0 |
Premium* |
|
|
Ocuphire Pharma, Inc |
OCUP |
|
2024-06-11 |
239,151 |
2020-11-05 |
0 |
Premium* |
|
|
Novavax Inc |
NVAX |
|
2024-06-12 |
10,470 |
2023-10-29 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
40 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 2
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| OCUP |
Ocuphire Pharma, Inc |
|
• • – |
2021-07-01 |
4 |
A |
$0.00 |
$0 |
D/D |
2,840 |
29,061 |
0 |
- |
|
| OCUP |
Ocuphire Pharma, Inc |
|
• • – |
2021-10-01 |
4 |
A |
$0.00 |
$0 |
D/D |
2,912 |
31,973 |
0 |
- |
|
| OCUP |
Ocuphire Pharma, Inc |
|
• • – |
2022-01-03 |
4 |
A |
$0.00 |
$0 |
D/D |
4,021 |
35,994 |
0 |
- |
|
| OCUP |
Ocuphire Pharma, Inc |
|
• • – |
2022-04-01 |
4 |
A |
$0.00 |
$0 |
D/D |
4,629 |
40,623 |
0 |
- |
|
| ARDX |
Ardelyx Inc |
Director |
– • – |
2022-06-15 |
4 |
A |
$0.00 |
$0 |
D/D |
132,299 |
219,826 |
0 |
- |
|
| OCUP |
Ocuphire Pharma, Inc |
|
• • – |
2022-07-01 |
4 |
A |
$0.00 |
$0 |
D/D |
23,653 |
64,276 |
0 |
- |
|
| OCUP |
Ocuphire Pharma, Inc |
|
• • – |
2022-10-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,148 |
67,424 |
0 |
- |
|
| OCUP |
Ocuphire Pharma, Inc |
|
• • – |
2023-01-11 |
4 |
A |
$0.00 |
$0 |
D/D |
20,822 |
88,246 |
0 |
- |
|
| OCUP |
Ocuphire Pharma, Inc |
Interim CEO and President |
• • – |
2023-04-19 |
4 |
A |
$0.00 |
$0 |
D/D |
50,000 |
138,246 |
0 |
- |
|
| ARDX |
Ardelyx Inc |
Director |
– • – |
2023-06-15 |
4 |
A |
$0.00 |
$0 |
D/D |
18,494 |
238,320 |
0 |
- |
|
| NVAX |
Novavax Inc |
Director |
– • – |
2023-10-29 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,800 |
3,800 |
0 |
- |
|
| OCUP |
Ocuphire Pharma, Inc |
|
• • – |
2023-11-01 |
4 |
A |
$0.00 |
$0 |
D/D |
35,000 |
173,246 |
0 |
- |
|
| OCUP |
Ocuphire Pharma, Inc |
|
• • – |
2024-01-01 |
4 |
A |
$0.00 |
$0 |
D/D |
24,762 |
198,008 |
0 |
- |
|
| OCUP |
Ocuphire Pharma, Inc |
|
• • – |
2024-06-11 |
4 |
A |
$0.00 |
$0 |
D/D |
41,143 |
239,151 |
0 |
- |
|
| NVAX |
Novavax Inc |
|
• • – |
2024-06-12 |
4 |
OE |
$0.00 |
$0 |
D/D |
6,670 |
10,470 |
0 |
- |
|
40 Records found
|
|
Page 2 of 2 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
